Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit. Biomed. Res. Ther. 2024, 11 (4), 6305-6325. https://doi.org/10.15419/bmrat.v11i4.877.